BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blackwell JA, Rodgers JB, Franco RA, Cofield SS, Walter LA, Galbraith JW, Hess EP. Predictors of linkage to care for a nontargeted emergency department hepatitis C screening program. Am J Emerg Med 2020;38:1396-401. [PMID: 31836342 DOI: 10.1016/j.ajem.2019.11.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee JS, Choi HJ, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Kim SU. Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South Korea. J Gastroenterol Hepatol 2021. [PMID: 33788314 DOI: 10.1111/jgh.15514] [Reference Citation Analysis]
2 Daniel Moore J, Galbraith J, Humphries R, Havens JR. Prevalence of Hepatitis C Virus Infection Identified From Nontargeted Screening Among Adult Visitors in an Academic Appalachian Regional Emergency Department. Open Forum Infect Dis 2021;8:ofab374. [PMID: 34381848 DOI: 10.1093/ofid/ofab374] [Reference Citation Analysis]
3 Sims OT, Truong DN, Wang K, Melton PA, Atim K. Time to HCV Treatment Disfavors Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center. J Racial Ethn Health Disparities 2021. [PMID: 34254269 DOI: 10.1007/s40615-021-01105-5] [Reference Citation Analysis]
4 Faryar KA, Henderson H, Wilson JW, Hansoti B, May LS, Schechter-Perkins EM, Waxman MJ, Rothman RE, Haukoos JS, Lyons MS; EMTIDE (Emergency Medicine Transmissible Infectious Diseases and Epidemics), Society for Academic Emergency Medicine. COVID-19 and beyond: Lessons learned from emergency department HIV screening for population-based screening in healthcare settings. J Am Coll Emerg Physicians Open 2021;2:e12468. [PMID: 34189516 DOI: 10.1002/emp2.12468] [Reference Citation Analysis]
5 Gerber E, Gelberg L, Cowan E, Mijanovich T, Shelley D, Gulati R, Wittman I, Doran KM. Health-Related Social Needs Among Emergency Department Patients with HIV. AIDS Behav 2021;25:1968-74. [PMID: 33385278 DOI: 10.1007/s10461-020-03126-3] [Reference Citation Analysis]
6 Trooskin S, Jhaveri R. Conversations With the Editors: Hepatitis C Virus-Where are We Now and Where Do We Go From Here? Clin Ther 2020;42:1425-32. [PMID: 32778344 DOI: 10.1016/j.clinthera.2020.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Blanding DP, Moran WP, Bian J, Zhang J, Marsden J, Mauldin PD, Rockey DC, Schreiner AD. Linkage to specialty care in the hepatitis C care cascade. J Investig Med 2021;69:324-32. [PMID: 33203787 DOI: 10.1136/jim-2020-001521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ohringer AR, Serota DP, McLean RL, Stockman LJ, Watt JP. Disparities in risk perception and low harm reduction services awareness, access, and utilization among young people with newly reported hepatitis C infections in California, 2018. BMC Public Health 2021;21:1435. [PMID: 34289822 DOI: 10.1186/s12889-021-11492-3] [Reference Citation Analysis]
9 Lin J, Mauntel-Medici C, Maheswaran AB, Baghikar S, Pugach O, Stein EM, Martin MT, Nguyen H. Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictor. J Public Health (Oxf) 2021:fdaa276. [PMID: 33539524 DOI: 10.1093/pubmed/fdaa276] [Reference Citation Analysis]